Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (58,694)	$ (37,517)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss from Equity Method Investment in the Joint Venture		39,554
Depreciation and amortization	138,541
Amortization of capitalized software developed for sale	78
Accretion and changes in estimate with related parties, net	5,895
Equity compensation	9,583
Deferred income tax expense (benefit)	(13,845)	(2,184)
Amortization of debt discount and issuance costs	8,047
Contingent consideration	(2,450)
Gain on sale of businesses	(28,095)
Other, net	14,618
Changes in operating assets and liabilities:
Accounts receivable, net	113,470
Contract assets, net	10,013
Prepaid expenses and other	(24,632)
Accounts payable	(19,244)
Accrued expenses and other liabilities	(4,852)	168
Deferred revenue	20,667
Due from the Joint Venture		(201)
Income taxes receivable		180
Net cash provided by (used in) operating activities	169,100
Cash flows from investing activities:
Acquisitions, net of cash acquired	(398,651)
Capitalized expenditures	(66,770)
Proceeds from sale of businesses	28,553
Other, net	1,039
Net cash provided by (used in) investing activities	(435,829)
Cash flows from financing activities:
Payments on Revolving Facility	(250,000)
Proceeds from issuance of Senior Notes	325,000
Payment of loan costs	(5,364)
Payments under tax receivable agreements with related parties	(20,691)
Receipts (payments) on derivative instruments	(7,364)
Debt Component, Issuance costs	(5,788)
Repayment of senior amortizing notes	(4,028)
Proceeds from exercise of equity awards	2,143
Payments on finance leases	(179)
Net cash provided by (used in) financing activities	33,729
Effect of exchange rate changes on cash and cash equivalents	946
Net increase (decrease) in cash and cash equivalents	(232,054)
Cash and cash equivalents at beginning of period	410,405	3,409
Cash and cash equivalents at end of period	$ 178,351	$ 3,409